PET scan test for prostate cancer that may have returned
Part of Cancer clinical trials.
This trial tests a new injection called INR101 that helps a PET/CT scan find prostate cancer that might have come back after initial treatment. It is for men with rising PSA levels who may need more treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 or older
- You have been diagnosed with prostate cancer that was treated with surgery or radiation, and your PSA level is now rising
- You are able to get a PET/CT scan
- Your overall health is good (able to care for yourself, ECOG score 0 or 1)
- Your blood counts and liver/kidney function are adequate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at using a PSMA PET/CT scan to better re-check cancer activity in men whose PSA has started rising after prostate removal. If you qualify, the scan may help doctors choose the next best treatment step.
This trial tests a targeted radiation therapy (PSMA-RLT) for men whose prostate cancer has returned after initial treatment, shown only by rising PSA levels. It aims to control the cancer without using hormone therapy.
This trial tests a new imaging agent called INR101 to improve PET/CT scans for prostate cancer. It is for men with intermediate-risk or higher localized prostate cancer who are planning to have their prostate removed along with nearby lymph nodes. The goal is to see how well INR101 helps doctors see cancer during imaging.
This Phase 3 trial tests whether a special PET scan using 68Ga-PSMA-11 can detect prostate cancer that has returned after surgery or radiation, measured by rising PSA. If the scan works well, it may help doctors find where the cancer is coming back.
This study tests a new type of PET scan (a detailed imaging test) to find out if prostate cancer has come back after treatment. You'll receive an injection of a special tracer and then have a scan that takes pictures to help doctors locate any cancer.
This trial tests a new imaging drug, 18F-Florastamin, to see if it can better detect prostate cancer that has come back after treatment. You may qualify if you have signs of recurrence and are willing to have a biopsy or additional therapy.
Hear when a new Prostate Cancer Recurrent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.